Mina Makaryus, MD
Critical Care Medicine · New Hyde Park, NYNPI 1366684896
Payments from drug & device makers
What this record shows
That places this record below the midpoint for critical care medicine clinicians in NY, where the typical reported total is $204.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 68 payments — averaging $3259.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$95K
- Amgen$50K
- Incyte Corporation$44K
- Astrazeneca UK Limited$24K
- AstraZeneca$9K
How this compares
$0 in reported general payments places this provider in the 0th percentile of 442 critical care medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 121 | $114,483 |
| Dupixent PenDupilumab | 26 | $92,794 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 40 | $30,354 |
| Breo ElliptaFluticasone/Vilanterol | 48 | $21,021 |
| XolairOmalizumab | 11 | $13,753 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 30 | $13,686 |
| SymbicortBudesonide/Formoterol Fumarate | 25 | $5,484 |
| DuleraMometasone/Formoterol | 12 | $4,127 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 87 | $3,970 |
| Arnuity ElliptaFluticasone Furoate | 15 | $3,825 |
| Fluticasone Propionate | 243 | $3,429 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $2,726 |
| Azelastine Hcl | 72 | $2,702 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $2,103 |
| Famotidine | 24 | $1,257 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in New Hyde Park
- Mangala NarasimhanNew Hyde Park$5K
- Rafael BarreraNew Hyde Park$3K
- Joshua RosenbergBrooklyn$881K
- Peter DicpinigaitisBronx$241K
- Roxana SulicaNew York$211K
- Boris ShkolnikAlbany$209K
- Paul StrachanMelville$169K
- Anna PodolanczukNew York$116K
- Joanne HessneyRochester$76K
- Jan BakkerNew York$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.